Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease psoriasis
Symptom C0028754|obesity
Sentences 27
PubMedID- 24095656 However, such a remarkable association of abdominal obesity with late onset psoriasis may suggest that obesity can be one of the acquired factors that may predispose for the development of psoriasis in the elderly.
PubMedID- 24474099 The occurrence of dyslipidemia and obesity in patients with psoriasis can affectlife quality and expectancy, increasing the risk of systemic and metabolicdiseases, which makes periodic investigation of these comorbidities in patientswith psoriasis mandatory.
PubMedID- 23110708 Background: chronic plaque psoriasis is associated with obesity, which is a metabolic and inflammatory disorder.
PubMedID- 23208415 Results: using random-effects meta-analysis, the pooled odds ratio (or) for obesity among patients with psoriasis was 1.66 (95% confidence interval (ci) 1.46-1.89) compared with those without psoriasis.
PubMedID- 22121277 Used the general practice research database and found higher rates of diabetes mellitus, hypertension, hyperlipidemia, obesity, and smoking in patients with psoriasis than in controls.
PubMedID- 22691169 Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.
PubMedID- 24556829 psoriasis is associated with obesity and other cardiovascular risk factors including endothelial dysfunction.
PubMedID- 20415822 Not only the obesity may be associated with higher psoriasis incidence and activity, and prevalence of obesity-related syndromes, but it may also influence the therapeutic approach to disease and the clinical response to systemic treatment.
PubMedID- 26202333 Background: psoriasis is frequently associated with obesity which possibly contributes to reduced treatment response.
PubMedID- 25381984 psoriasis is frequently associated with obesity, which may favor the development of hyperuricemia.
PubMedID- 22356630 Both conditions are likely to also interact at a functional level because obesity and the up-regulation of pro-inflammatory mediators in psoriasis appear to influence adipocyte homoeostasis, inducing non-professional immune functions.
PubMedID- 19887761 Background: psoriasis is associated with obesity and metabolic syndrome.
PubMedID- 22120603 Objectives: to compare obesity among individuals with psa, psoriasis (pso), ra and the general population (n), and identify correlates of obesity among individuals with pso and psa.
PubMedID- 20034760 Environmental risk factors including streptococcal pharyngitis, stressful life events, low humidity, drugs, hiv infection, trauma, smoking and obesity have been associated with psoriasis and psa.
PubMedID- 26015779 On the genetic basis, the most important susceptibility locus for psoriasis, hla-cw6, is associated with obesity .
PubMedID- 24750404 psoriasis is associated with comorbidity including obesity, insulin resistance and diabetes mellitus type 2.
PubMedID- 23291856 psoriasis is associated with obesity accompanied by insulin resistance.
PubMedID- 24406087 obesity is associated with psoriasis and poses a significant obstacle to psoriasis management.
PubMedID- 25092612 Moreover, obesity worsens the course of ra, sle, ibd, psoriasis and psa, and impairs the treatment response of ra, ibd, psoriasis and psa.
PubMedID- 26271963 Objective: the objective of this systematic review is to determine the association of obesity with psoriasis severity.
PubMedID- 26054710 Numerous reports have shown that psoriasis is associated with obesity and leptin.
PubMedID- 25599394 Subsequently, a series of multiple studies reported a higher risk for various cardiometabolic traits (including hypertension, t2d, hyperlipidemia, hypercholesterolemia and obesity) in patients with psoriasis, in particular those with severe and widespread forms (kimball and wu, 2009; langan et al., 2012; yeung et al., 2013).
PubMedID- 22584116 Additionally, it is now well established that obesity is associated with psoriasis .
PubMedID- 23848131 Objectives: to evaluate the prevalence of overweight and obesity in patients with moderate-to-severe psoriasis compared to the general population and to assess the relationship between body mass index (bmi) and the risk of discontinuing treatment.
PubMedID- 21492252 obesity is associated with psoriasis and contributes significantly to the increased cardiovascular risk in these patients.
PubMedID- 24592364 Apart from the predictable association of psoriasis with obesity and metabolic syndrome, a detailed history was taken from each patient regarding involved or deteriorating factors (bacterial infections, human immunodeficiency virus infection, pregnancy, hypocalcemia and causative drug consumption including terbinafine, non-steroidal anti-inflammatory drugs, anti-malarias, angiotensin-converting enzyme inhibitors, lithium, interferon ifn and beta blockers).
PubMedID- 22113483 Or 1.14 (95% ci 1.03-1.27), 34% increase in obesity with moderate psoriasis, adj.

Page: 1